Amgen announces $1 billion expansion in Holly Springs

(2:17)

Amgen shares sink despite quarterly beat, FDA places obesity drug on clinical hold

(39)

Amgen Announced Definitive Agreement To Acquire BioVex

(1:14)

Introducing Amgen’s RISE Program

(1:1econd)

Amgen sinks as Cantor flags issues with obesity drug

(4:48)

AGT-103T Clinical Trials: Phase 1 Results \u0026 What’s Next

(15:38)

Biotechnology and Healthcare: A New Dawn? CEO Bob Bradway on Money Maze Podcast

(35:47)

Regulation of Osteoclast Activity

(2:31)

The Problem with Nuclear Fusion

(17:4)

The Challenges in Manufacturing Biologics

(5:9)

Learn About the Rare Disease Community: Meet Leigh-Ana Rossitto

(5:52)

Amgen: How Biotechnology is Transforming Medicine

(10:40)

AWS re:Invent 2023 - Omics innovation with AWS HealthOmics: Amgen’s path to faster results (AIM215)

(40:50)

Amgen Science - Biotechnology for the Next Decade

(2:41)

The Next Generation of Biomanufacturing at Amgen

(2:58)

Amgen has great science, but they don't seem to make it across the finish line, says Jim Cramer

(2:7)

Jefferies' Michael Yee still likes Amgen in the biotech sector

(3:33)

Amgen to buy Horizon Therapeutics, U.S. to announce nuclear breakthrough and more

(1:42)

Amgen Inc. (AMGN): A Deep Dive into the Biotech Giant

(5:16)

The Amgen operations team shares a common goal to serve every patient, every time.

(37)

How Amgen is using Generative Biology and AI

(2:31)

The Amgen Difference - Our People, Our Values

(3:36)

The Race to Get New Medicines to Patients

(1:33)

Amgen Said to Agree to $26 Billion Purchase of Horizon

(55)

Amgen breaks ground on $200M 'next-generation' plant in RI

(1:48)

Chart of the Day: Amgen

(6:41)

Amgen CEO Robert Bradway discusses the Amgen Foundation's partnership with Khan Academy

(1:35)

$AMGN Amgen Inc Q2 2024 Earnings Conference Call

(1:4:47)

Can Amgen Be a Market-Beating Stock?

(7:17)